During the past decade, Velocity Clinical Research, Spokane conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Velocity Clinical Research, Spokane" #1 sponsor was "Celgene" with 2 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Exact Sciences Corporation" with 1 trials sponsored, "Galectin Therapeutics Inc." with 1 trials sponsored and "Guardant Health, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Velocity Clinical Research, Spokane" #1 collaborator was "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Velocity Clinical Research, Spokane" are "Cirrhosis" (2 trials), "Crohn's Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials), "Ulcerative Colitis" (2 trials) and "CDI" (1 trials). Many other conditions were trialed in "Velocity Clinical Research, Spokane" in a lesser frequency.

Most popular intervention types in "Velocity Clinical Research, Spokane" are "Drug" (9 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "CC-93538" (2 trials), "BT-11 1,000 mg" (1 trials), "Guselkumab" (1 trials) and "Mirikizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Velocity Clinical Research, Spokane" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Velocity Clinical Research, Spokane". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Velocity Clinical Research, Spokane, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Velocity Clinical Research, Spokane, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".